Compare SITM & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SITM | TECH |
|---|---|---|
| Founded | 2003 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.2B |
| IPO Year | 2019 | 1995 |
| Metric | SITM | TECH |
|---|---|---|
| Price | $332.59 | $52.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 12 |
| Target Price | ★ $390.71 | $73.09 |
| AVG Volume (30 Days) | 328.6K | ★ 2.0M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.61% |
| EPS Growth | ★ 57.53 | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | $326,660,000.00 | ★ $1,219,635,000.00 |
| Revenue This Year | $49.65 | $2.49 |
| Revenue Next Year | $27.77 | $6.40 |
| P/E Ratio | ★ N/A | $107.59 |
| Revenue Growth | ★ 61.16 | 5.23 |
| 52 Week Low | $105.42 | $46.02 |
| 52 Week High | $446.96 | $72.16 |
| Indicator | SITM | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 43.29 | 42.31 |
| Support Level | $331.93 | $49.30 |
| Resistance Level | $387.13 | $54.08 |
| Average True Range (ATR) | 24.42 | 2.16 |
| MACD | -0.01 | 0.42 |
| Stochastic Oscillator | 37.20 | 64.92 |
SiTime Corp is a provider of silicon timing systems solutions. The company designs develops and sell silicon timing systems solutions for different industries including automotive, infrastructure, aerospace-defense, consumer, internet of things, consumer and industrials. Its product offerings include Stratum 3E DCOCXOs, Programmable OCXOs, MHz Oscillators, 32.768 kHz Oscillators, Embedded Resonators, Precision MHz Super-TCXOs, and Ruggedized Oscillators. It sells its products around Taiwan, Hong Kong, the United States, and other regions and generates the majority of its revenue from Taiwan.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.